Potential Leptin Receptor Response Modifier Peptides
Laszlo OtvosA OLPE, LLC, Audubon, PA 19403, USA; Arrevus, Inc., Raleigh, NC 27612, USA; and Institute of Medical Microbiology, Semmelweis University, Budapest 1085, Hungary. Email: laszlootvos@gmail.com
Laszlo Otvos, Ph.D., is the President of OLPE, LLC, a US-based pharmaceutical consulting firm. His main clients are Arrevus, Inc. and Allysta Inc., biotechnology companies that license his adipokine receptor response modifier and host defence peptide patents from Temple University. Dr Otvos is a senior consultant to Arrevus and Allysta. He also serves as an Adjunct Professor for Semmelweis University, Hungary, and Associate Editor for Frontiers in Chemical Biology. Dr Otvos is an author of over 250 peer-reviewed publications with a current h-factor of 63. His main goal is to bring as many peptide drugs to market as possible, either through personal involvement in the preclinical development process or through editorial and public educational activities. |
Australian Journal of Chemistry 73(4) 264-270 https://doi.org/10.1071/CH19407
Submitted: 21 August 2019 Accepted: 26 September 2019 Published: 8 November 2019
Abstract
Drug targets for the treatment of obesity and comorbidities represent an ever-renewable source of research opportunities worldwide. One of the earliest is the leptin–leptin receptor system that was discovered in the mid-1990s. Leptin, a satiety hormone, is overproduced in overweight patients but the protein is unable to cross the blood–brain barrier and remains inactive. Circulating high levels of leptin induces a series of conditions that would not be manifested without leptin overproduction, including various forms of cancer and inflammatory and cardiovascular diseases. Current pharmaceutical research focuses on improving the blood–brain barrier penetration of leptin receptor agonists and the development of monofunctional antagonists with broad spectrum therapeutic efficacies but without unwanted side effects. Designer peptides with their expanded chemical space as well as well controllable receptor binding and elimination properties slowly replace full-sized leptin products in the drug development pipeline.
References
[1] Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J. M. Friedman, Nature 1994, 372, 425.| Crossref | GoogleScholarGoogle Scholar | 7984236PubMed |
[2] J. L. Halaas, K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabinowitz, R. L. Lallone, S. K. Burley, J. M. Friedman, Science 1995, 269, 543.
| Crossref | GoogleScholarGoogle Scholar | 7624777PubMed |
[3] G. Kolata, The New York Times 1995, 27 July. Available at: https://www.nytimes.com/1995/07/27/us/researchers-find-hormone-causes-a-loss-of-weight.html (accessed 20 August 2019)
[4] K. Chou, C. M. Perry, Drugs 2013, 73, 989.
| Crossref | GoogleScholarGoogle Scholar | 23740412PubMed |
[5] I. Hussain, A. Garg, Endocrinol. Metab. Clin. North Am. 2016, 45, 783.
| Crossref | GoogleScholarGoogle Scholar | 27823605PubMed |
[6] Globesnewswire, 2019, 14 March. Available at https://www.globenewswire.com/news-release/2019/03/14/1754886/0/en/Novelion-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2018-Financial-Results.html (accessed 20 August 2019)
[7] J. L. Halaas, C. Boozer, J. Blair-West, N. Fidahusein, D. A. Denton, J. M. Friedman, Proc. Natl. Acad. Sci. USA 1997, 94, 8878.
| Crossref | GoogleScholarGoogle Scholar | 9238071PubMed |
[8] L. A. Tartaglia, J. Biol. Chem. 1997, 272, 6093.
| Crossref | GoogleScholarGoogle Scholar | 9102398PubMed |
[9] C. Bjorbaek, S. Uotani, B. da Silva, J. S. Flier, J. Biol. Chem. 1997, 272, 32686.
| Crossref | GoogleScholarGoogle Scholar | 9405487PubMed |
[10] R. S. Ahima, Trends Endocrinol. Metab. 2005, 16, 307.
| Crossref | GoogleScholarGoogle Scholar | 16098759PubMed |
[11] C. Roujeau, R. Jockers, J. Dam, Front. Endocrinol. 2014, 5, 167.
| Crossref | GoogleScholarGoogle Scholar |
[12] T. D. Müller, L. M. Sullivan, K. Habegger, C.-X. Yi, D. Kabra, E. Grant, N. Ottaway, R. Krishna, J. Holland, J. Hembree, D. Perez-Tilve, P. T. Pfluger, M. J. DeGuzman, M. E. Siladi, V. S. Kraynov, D. W. Axelrod, R. DiMarchi, J. K. Pinkstaff, M. H. Tschöp, J. Pept. Sci. 2012, 18, 383.
| Crossref | GoogleScholarGoogle Scholar | 22565812PubMed |
[13] C. Garofalo, E. Surmacz, J. Cell. Physiol. 2006, 207, 12.
| Crossref | GoogleScholarGoogle Scholar | 16110483PubMed |
[14] M. Bokarewa, D. Bokarew, O. Hultgren, A. Tarkowski, Ann. Rheum. Dis. 2003, 62, 952.
| Crossref | GoogleScholarGoogle Scholar | 12972473PubMed |
[15] A. C. Huby, L. Otvos, E. J. Belin de Chantemèle, Hypertension 2016, 67, 1020.
| Crossref | GoogleScholarGoogle Scholar | 26953321PubMed |
[16] F. Peelman, K. Van Beneden, L. Zabeau, H. Iserentant, P. Ulrichts, D. Defeau, A. Verhee, D. Catteeuw, D. Elewaut, J. Tavernier, J. Biol. Chem. 2004, 279, 41038.
| Crossref | GoogleScholarGoogle Scholar | 15213225PubMed |
[17] M. Shpilman, L. Niv-Spector, M. Katz, C. Varol, G. Solomon, M. Ayalon-Soffer, E. Boder, Z. Halpern, E. Elinav, A. Gertler, J. Biol. Chem. 2011, 286, 4429.
| Crossref | GoogleScholarGoogle Scholar | 21119198PubMed |
[18] L. Otvos, M. Terrasi, S. Cascio, M. Cassone, G. Abbadessa, F. De Pascali, L. Scolaro, D. Knappe, M. Stawikowski, P. Cudic, J. D. Wade, R. Hoffmann, E. Surmacz, Biochim. Biophys. Acta 2008, 1783, 1745.
| Crossref | GoogleScholarGoogle Scholar | 18555805PubMed |
[19] S. Beccari, I. Kovalszky, J. D. Wade, L. Otvos, E. Surmacz, Peptides 2013, 44, 127.
| Crossref | GoogleScholarGoogle Scholar | 23567149PubMed |
[20] B. Carpenter, S. Pradhananga, I. Wilkinson, S. Justice, P. Artymiuk, R. Ross, Endocrine Abstracts 2009, 19, 114.
[21] C. Zhang, Z. Su, B. Zhao, Q. Qu, Y. Tan, L. Cai, X. Li, Exp. Clin. Endocrinol. Diabetes 2010, 118, 31.
| Crossref | GoogleScholarGoogle Scholar | 19472101PubMed |
[22] T. O. Price, S. A. Farr, X. Yi, S. Vinogradov, E. Batrakova, W. A. Banks, A. V. Kabanov, J. Pharmacol. Exp. Ther. 2010, 333, 253.
| Crossref | GoogleScholarGoogle Scholar | 20053933PubMed |
[23] P. Grasso, M. C. Leinung, S. P. Ingher, D. W. Lee, Endocrinology 1997, 138, 1413.
| Crossref | GoogleScholarGoogle Scholar | 9075696PubMed |
[24] P. Grasso, D. W. White, L. A. Tartaglia, M. C. Leinung, D. W. Lee, Diabetes 1999, 48, 2204.
| Crossref | GoogleScholarGoogle Scholar | 10535455PubMed |
[25] M. Rozhavskaya-Arena, D. W. Lee, M. C. Leinung, P. Grasso, Endocrinology 2000, 141, 2501.
| Crossref | GoogleScholarGoogle Scholar | 10875251PubMed |
[26] Z. M. Novakovic, M. C. Leinung, D. W. Lee, P. Grasso, Regul. Pept. 2009, 154, 107.
| Crossref | GoogleScholarGoogle Scholar | 19344673PubMed |
[27] P. Grasso, D. W. Lee, M. C. Leinung, US Patent 7 208 572 2007.
[28] A. D. Kline, G. W. Becker, L. M. Churgay, B. E. Landen, D. K. Martin, W. L. Muth, R. Rathnachalam, J. M. Richardson, B. Schoner, M. Ulmer, J. E. Hale, FEBS Lett. 1997, 407, 239.
| Crossref | GoogleScholarGoogle Scholar | 9166907PubMed |
[29] F. Zhang, Y. Chen, M. Heiman, R. DiMarchi, Vitam. Horm. 2005, 71, 345.
| Crossref | GoogleScholarGoogle Scholar | 16112274PubMed |
[30] W. K. Samson, T. C. Murphy, D. Robison, T. Vargas, E. Tau, J. K. Chang, Endocrinology 1996, 137, 5182.
| Crossref | GoogleScholarGoogle Scholar | 8895397PubMed |
[31] X. Hu, J. C. Juneja, M. J. Maihle, M. P. Cleary, J. Natl. Cancer Inst. 2002, 94, 1704.
| Crossref | GoogleScholarGoogle Scholar | 12441326PubMed |
[32] D. Knappe, L. Otvos, F. De Pascali, M. Cassone, L. Scolaro, G. Abbadessa, C. Carrillo-Infante, M. F. Kiani, F. Donelson, R. Hoffmann, E. Surmacz, Int. J. Pept. Res. Ther. 2008, 14, 247.
| Crossref | GoogleScholarGoogle Scholar |
[33] R. Polt, F. Porreca, L. Z. Szabo, E. J. Bilsky, P. Davis, T. J. Abbruscato, T. P. Davis, R. Harvath, H. I. Yamamura, V. J. Hruby, Proc. Natl. Acad. Sci. USA 1994, 91, 7114.
| Crossref | GoogleScholarGoogle Scholar | 8041755PubMed |
[34] L. Otvos Jr, M. Cassone, J. D. Wade, D. Knappe, R. Hoffmann, B. Henry, I. Clarke, E. Surmacz, in Peptides 2008 (Ed. H. Lankinen) 2009, pp. 436–437 (Finnish Peptide Society: Helsinki).
[35] I. Kovalszky, E. Surmacz, L. Scolaro, M. Cassone, R. Ferla, A. Sztodola, J. Olah, M. P. Hatfield, S. Lovas, L. Otvos, Diabetes Obes. Metab. 2010, 12, 393.
| Crossref | GoogleScholarGoogle Scholar | 20415687PubMed |
[36] W. A. Banks, A. J. Kastin, J. Neurosci. Res. 1998, 54, 522.
| Crossref | GoogleScholarGoogle Scholar | 9822162PubMed |
[37] V. J. Hruby, Nat. Rev. Drug Discovery 2002, 1, 847.
| Crossref | GoogleScholarGoogle Scholar | 12415245PubMed |
[38] L. O. Sillerud, R. S. Larson, Curr. Protein Pept. Sci. 2005, 6, 151.
| Crossref | GoogleScholarGoogle Scholar | 15853652PubMed |
[39] K. A. Vessey, K. A. Lencses, D. A. Rushforth, V. J. Hruby, W. K. Stell, Invest. Ophthalmol. Vis. Sci. 2005, 46, 3922.
| Crossref | GoogleScholarGoogle Scholar | 16249465PubMed |
[40] H. Lempiainen, F. Molnar, M. M. Gonzalez, M. Perakyla, C. Carlberg, Mol. Endocrinol. 2005, 19, 2258.
| Crossref | GoogleScholarGoogle Scholar | 15905360PubMed |
[41] A. Higginbottom, S. A. Cain, T. M. Woodruff, L. M. Proctor, P. K. Madala, J. D. A. Tyndall, S. M. Taylor, D. P. Fairlie, P. N. Monk, J. Biol. Chem. 2005, 280, 17831.
| Crossref | GoogleScholarGoogle Scholar | 15661745PubMed |
[42] L. Otvos, I. Kovalszky, M. Riolfi, R. Ferla, J. Olah, A. Sztodola, L. Nama, A. Molino, Q. Piubello, J. D. Wade, E. Surmacz, Eur. J. Cancer 2011, 47, 1578.
| Crossref | GoogleScholarGoogle Scholar | 21353530PubMed |
[43] L. Otvos, I. Kovalszky, L. Scolaro, A. Sztodola, J. Olah, M. Cassone, D. Knappe, R. Hoffmann, S. Lovas, H. P. Hatfield, G. Beko, S. Zhang, J. D. Wade, E. Surmacz, Biopolymers 2011, 96, 117.
| Crossref | GoogleScholarGoogle Scholar | 20564005PubMed |
[44] I. Martins, S. Gomes, R. O. Costa, L. Otvos, C. R. Oliveira, R. Resende, C. M. Pereira, Neuroscience 2013, 241, 41.
| Crossref | GoogleScholarGoogle Scholar | 23506735PubMed |
[45] Z. B. You, B. Wang, Q. R. Liu, Y. Wu, L. Otvos, R. A. Wise, Neuropsychopharmacology 2016, 41, 1024.
| Crossref | GoogleScholarGoogle Scholar | 26243270PubMed |
[46] L. Otvos, S. W. Vetter, M. Koladia, D. Knappe, R. Schmidt, E. Ostorhazi, I. Kovalszky, N. Bionda, P. Cudic, E. Surmacz, J. D. Wade, R. Hoffmann, Amino Acids 2014, 46, 873.
| Crossref | GoogleScholarGoogle Scholar | 24366600PubMed |
[47] S. T. Charlton, J. Whetstone, S. T. Fayinka, K. D. Read, L. Illum, S. S. Davis, Pharm. Res. 2008, 25, 1531.
| Crossref | GoogleScholarGoogle Scholar | 18293062PubMed |
[48] L. Otvos, E. Surmacz, Expert Rev. Anticancer Ther. 2011, 11, 1147.
| Crossref | GoogleScholarGoogle Scholar | 21916566PubMed |
[49] L. Otvos, W.-H. Shao, A. Vanniasinghe, M. A. Amon, M. C. Holub, I. Kovalszky, J. D. Wade, M. Doll, P. L. Cohen, N. Manolios, E. Surmacz, Peptides 2011, 32, 1567.
| Crossref | GoogleScholarGoogle Scholar | 21723351PubMed |
[50] R. Coroniti, R. Fario, D. J. Nuno, L. Otvos, L. Scolaro, E. Surmacz, Front. Mol. Biosci. 2016, 3, 67.
| Crossref | GoogleScholarGoogle Scholar | 27790618PubMed |
[51] M. W. Hamrick, A. Dukes, P. Arounleut, C. Davis, S. Periyasamy-Thandavan, S. Mork, S. Herberg, M. H. Johnson, C. M. Isales, W. D. Hill, L. Otvos, E. J. Belin de Chantemèle, Exp. Gerontol. 2015, 70, 92.
| Crossref | GoogleScholarGoogle Scholar | 26220769PubMed |
[52] L. Brunner, S. Whitebread, I. Leconte, A. Stricker-Krongrad, F. Cumin, M. Chiesi, N. Levens, Int. J. Obes. Relat. Metab. Disord. 1999, 23, 463.
| Crossref | GoogleScholarGoogle Scholar | 10375048PubMed |
[53] A. Gertler, E. Elinav, Curr. Pharm. Des. 2014, 20, 659.
| Crossref | GoogleScholarGoogle Scholar | 23688008PubMed |
[54] W. W. Cheung, W. Ding, S. S. Gunta, Y. Gu, R. Tabakman, L. N. Klapper, A. Gertler, R. H. Mak, J. Am. Soc. Nephrol. 2014, 25, 119.
| Crossref | GoogleScholarGoogle Scholar | 24115476PubMed |
[55] N. Chapnik, G. Solomon, Y. Genzer, R. Miskin, A. Gertler, O. Froy, J. Endocrinol. 2013, 217, 283.
| Crossref | GoogleScholarGoogle Scholar | 23482705PubMed |
[56] U. P. Singh, N. P. Singh, H. Guan, B. Busbee, R. L. Price, D. D. Taub, M. K. Mishra, R. Fayad, M. Nagarkatti, P. S. Nagarkatti, Int. Rev. Immunol. 2014, 33, 23.
| Crossref | GoogleScholarGoogle Scholar | 23841494PubMed |
[57] N. Tümer, B. Erdös, M. Matheny, I. Cudykier, P. J. Scarpace, J. Hypertens. 2007, 25, 2471.
| Crossref | GoogleScholarGoogle Scholar | 17984669PubMed |
[58] S. Catalano, A. Leggio, I. Barone, R. De Marco, L. Gelsomino, A. Campana, R. Malivindi, S. Panza, C. Giordano, A. Liguori, D. Bonofiglio, A. Liguori, S. Ando, J. Cell. Mol. Med. 2015, 19, 1122.
| Crossref | GoogleScholarGoogle Scholar | 25721149PubMed |
[59] C. Giordano, F. Chemi, S. Panza, I. Barone, D. Bonofiglio, M. Lanzino, A. Cordella, A. Campana, A. Hashim, P. Rizza, A. Leggio, B. Győrffy, B. M. Simões, R. B. Clarke, A. Weisz, S. Catalano, S. Ando, Oncotarget 2016, 7, 1262.
| Crossref | GoogleScholarGoogle Scholar | 26556856PubMed |
[60] K. Eitner, U. Koch, T. Gaweda, J. Marciniak, Bioinformatics 2010, 26, 2933.
| Crossref | GoogleScholarGoogle Scholar | 21030460PubMed |
[61] R. R. Gonzalez, P. C. Leavis, Endocrine 2003, 21, 185.
| Crossref | GoogleScholarGoogle Scholar | 12897384PubMed |
[62] R. R. Gonzalez, A. Watters, Y. Xu, U. P. Singh, D. R. Mann, B. R. Rueda, M. L. Penichet, Breast Cancer Res. 2009, 11, R36.
| Crossref | GoogleScholarGoogle Scholar |
[63] A. Harbuzariu, G. Oprea-Ilies, R. R. Gonzalez-Perez, in Advances in Pancreatic Cancer (Ed. L. Rodrigo), 2018, Ch. 2, pp. 31–51 (IntechOpen: London).
[64] M. Munikumar, V. S. Krishna, V. S. Reddy, B. Rajeswari, D. Sriram, M. V. Rao, J. Mol. Graph. Model. 2018, 82, 20.
| Crossref | GoogleScholarGoogle Scholar | 29649778PubMed |
[65] L. Scolaro, M. Cassone, J. W. Kolaczynski, L. Otvos, E. Surmacz, Expert Rev. Endocrinol. Metab. 2010, 5, 875.
| Crossref | GoogleScholarGoogle Scholar | 30780830PubMed |